Validation of a rapid point-of-care breath test for breast cancer
Ended Cooperative Agreement Awarded Last action
- Award ID
- R44CA203019
- Recipient
-
Menssana Research Inc. UEI N3KCXKLQNG35
- Awarding agency
-
National Cancer Institute
National Institutes of Health, Department of Health and Human Services
- Obligated
- $2,216,494
Award facts
- Assistance listing
- 93.394 Cancer Detection and Diagnosis Research
- Completion date
- Originally
- Place of performance
- Newark, NJ 07103, USA
Award details come from USAspending.gov.
Transactions
| Action | Obligated | Date |
|---|---|---|
| Amendment | $0 | |
| Amendment | $224,700 | |
| Amendment | $0 | |
| Amendment | $919,927 | |
| Original award | $1,071,867 |
Quick answers
Who received award R44CA203019?
R44CA203019 was awarded to Menssana Research Inc. by National Cancer Institute (National Institutes of Health) on April 5, 2016.
How much is award R44CA203019 worth?
$2,216,494 has been obligated on R44CA203019.
On GovTribe
See this award's full record
- Every transaction and subaward
- The recipient's other awards and teaming partners
- Similar grant awards
- Ask GovTribe AI about this award